Conference abstract
Conference abstract
Antibody-Proteases: Predictive and Preventive Tools
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Most of autoimmune diseases are preceded by a subclinical (symptom-free) stage in which the patients or persons at-risks could be identified by the presence of autoantibodies (autoAbs). Ab-proteases hydrolyze the antigenic (Ag) substrate in a specific manner while occuring in organ-related autoimmunity conditions. Anti-MBP autoAbs from MS patients and mice with experimental autoimmune encephalitis (EAE) were found to exhibit sequence-specific cleavage of MBP. The activity of Ab-proteases markedly differs: (i) between MS patients and healthy controls, (ii) among MS patients with different types of the clinical course and (iii) among MS patients with different scales of disability. Bursts of the Ab-associated proteolytic activity have been confirmed at the pre-early stages of the exacerbation to predict the latter, or prior to changing type of the clinical course, i.e., from a remitting type into the progradient one. The pattern of Ab-mediated proteolysis of MBP illustrates six sites of preferential proteolysis to be located predominantly within the immunodominant regions of the targeted MBP; two of those sites falling into the highly encephalitogenic sequence that proved to be a specific inducer of EAE. 28% of the direct relatives are seropositive for Ab- proteases. 50% of the seropositive relatives have been demonstrating stable growth of the Ab-associated proteolytic activity to reach levels close to the patients� one when the first (pre-early onset) MRI-manifestations had been identified. Ab-proteases may serve as biopredictors to monitor subclinical stages of MS to predict the outcome and as a promising target for newer therapeutic tools to produce preventive therapeutic effects at subclinical stages of MS.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Antibody-proteases as a generation of novel biomarkers and highly informative molecular tools to predict and to prevent demyelination
Conference abstract · 2020
Antibody-proteases as a unique target and thus the tool to be applied in regenerative medicine
Conference abstract · 6 Aug 2018
Antibody-proteases as a unique translational tool to be applied for bio-design and target-ed pharmacotherapy
Conference abstract · 7 May 2018
Antibody-proteases as a novel biomarker and a unique target to suit translational tools to be applied for biodesign and bioengineering
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “S. Suchkov”

